U.S. spots first monkeypox case in a pregnant woman as cases climb
While pregnant women are among those at the highest risk of severe disease, both mom and baby are "doing well" so far.
Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the Biden administration's public health agencies, including the federal response to infectious disease outbreaks like COVID-19. Previously, he was a campaign reporter for CBS News based out of Las Vegas, where he was raised. He covered presidential, Senate and House candidates for the 2020 election cycle in Arizona, California, Nevada and New Mexico. He has also worked in Washington for "Face the Nation" and in New York for the "CBS Evening News." Tin graduated from Columbia University in 2017 with a bachelor's degree in political science.
While pregnant women are among those at the highest risk of severe disease, both mom and baby are "doing well" so far.
Prior infections make clear answers tricky. Currently, the CDC estimates the BA.5 and BA.4 subvariants make up 95% of COVID cases in the U.S.
One case is in an infant who is a California resident and another is in a toddler who is not a U.S. resident, the CDC said.
More than 2.7 million courses of Paxlovid pills have been used to date to treat COVID-19 across the country.
The Biden administration is warning states that only "limited supply" of the recently authorized vaccine will be available.
The Chicago Department of Public Health offered monkeypox vaccinations at Steamworks Baths Chicago, 3246 N. Halsted St.
Novavax says it plans to begin shipping its first doses for distribution "in the coming days."
The Biden administration declared a public health emergency to help ramp up the federal response to monkeypox.
The nation's top infectious disease scientist has acknowledged for months that he was weighing a potential retirement.
The U.S. has tallied at least 1,470 cases in the monkeypox outbreak so far.
The percentage of Americans living in areas of "high" COVID-19 Community Levels is the worst since the metric was first rolled out in February.
The Biden administration says it has secured 3.2 million doses of the vaccine.
After the results were first released in April, Veru asked the FDA for emergency use authorization of sabizabulin.
There was such high demand from New Yorkers wanting the shots that the city had to close its vaccination clinic to walk-ins.
Moderna's request had been stalled for months as regulators studied whether it posed a higher risk of rare heart inflammation side effects.